3-(3-methyl-1H-pyrazole-1-carbonyl)-2H-chromen-2-one

Compound number
MolPort-000-519-441
IUPAC
3-(3-methyl-1H-pyrazole-1-carbonyl)-2H-chromen-2-one
IUPAC traditional
3-(3-methylpyrazole-1-carbonyl)chromen-2-one
SMILES
Cc1ccn(n1)C(=O)c1cc2ccccc2oc1=O
InChI key
FCAGWSVPZLZEKA-UHFFFAOYSA-N
Molecular formula
Molecular weight
254.245
DMSO Solubility
Not known

Marketplace Offers

Otava, Ltd.

Direct S&H to USA:
105.00 USD
Catalog
Screening compound
Ships out
15 business days
Purity
90.00
Last updated
> 3 months ago
In warehouse
65.00 mg

Supplier Catalogue Data

Pack size Ships out Price Quantity
5 micromol October 24, 2022 42.70 USD
Add to Cart Buy
10 micromol October 24, 2022 54.90 USD
Add to Cart Buy
20 micromol October 24, 2022 65.90 USD
Add to Cart Buy

ChemBridge Corporation

Direct S&H to USA:
45.00 USD
Catalog
Screening compound
Ships out
20 business days
Purity
90.00
Last updated
this week
In warehouse
25.00 mg
Salt: FREE

Supplier Catalogue Data

Pack size Ships out Price Quantity
5 micromol October 31, 2022 50.00 USD
Add to Cart Buy
1 mg October 31, 2022 44.00 USD
Add to Cart Buy
5 mg October 31, 2022 55.00 USD
Add to Cart Buy

Get your compounds in the right format

Molport Reweighting and Reformatting Services

More Information

Compound identifiers

Compound number
MolPort-000-519-441

Names, Synonyms and 3rd Party Identifiers

Name
3-[(3-methyl-1H-pyrazol-1-yl)carbonyl]-2H-chromen-2-one

InChI

InChI
1/C14H10N2O3/c1-9-6-7-16(15-9)13(17)11-8-10-4-2-3-5-12(10)19-14(11)18/h2-8H,1H3
InChI key
FCAGWSVPZLZEKA-UHFFFAOYSA-N

Formula

Molecular formula
C14H10N2O3
Molecular weight
254.245

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback